Discontinuing caffeine in preterm infants at 33-35 weeks corrected gestational age: Failure rate and predictive factors

Journal of Neonatal-Perinatal Medicine

Volumn 8, Issue 1, 2015, Pages 41-45

  Haddad, Wajed ^a   Sajous, Christine ^a   Hummel, Pat ^a   Guo, Rong ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Caffeine; predictive factors

Indexed keywords

CAFFEINE;

ARTICLE; BRADYCARDIA; BRAIN HEMORRHAGE; CLINICAL PRACTICE; COMORBIDITY; DEMOGRAPHY; DRUG WITHDRAWAL; ETHNICITY; FEMALE; GESTATIONAL AGE; HISPANIC; HOSPITAL DISCHARGE; HUMAN; INFANT; LEUKOMALACIA; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NECROTIZING ENTEROCOLITIS; NEWBORN APNEA; PATIENT MONITORING; PATIENT TRANSPORT; PERIVENTRICULAR LEUKOMALACIA; PREMATURITY; PRIORITY JOURNAL; RISK FACTOR;

EID: 84930243839     PISSN: 19345798     EISSN: 18784429     Source Type: Journal    
DOI: 10.3233/NPM-15814071     Document Type: Article

References (18)

1. Zhao J, Gonzalez F, Mu D. Apnea of prematurity: From cause to treatment. Eur J Pediatr 2011;170(9):1097-105.
2. Finer NN, Higgins R, Kattwinkel J, Martin RJ. Summary proceedings from the apnea-of-prematurity group. Pediatrics 2006;117(3 Pt 2):S47-51.
3. Baird TM, Martin RJ, Abu-Shaweesh JM. Clinical Associations, Treatment, and Outcome of Apnea of Prematurity. NeoReviews 2002;3(4):e66-e70.
4. Picone S, Bedetta M, Paolillo P. Caffeine citrate: When and for how long. A literature review. J Matern Fetal Neonatal Med 2012;25 Suppl 3:11-4.
5. Julien CA, Joseph V, Bairam A. Caffeine reduces apnea frequency and enhances ventilatory long-term facilitation in rat pups raised in chronic intermittent hypoxia. Pediatr Res 2010;68(2):105-11.
6. Kassim Z, Greenough A, Rafferty GF. Effect of caffeine on respiratory muscle strength and lung function in prematurely born, ventilated infants. Eur J Pediatr 2009;168(12):1491-5.
7. Erenberg A, Leff RD, Haack DG, Mosdell KW, Hicks GM, Wynne BA. Caffeine citrate for the treatment of apnea of prematurity: A double-blind, placebo-controlled study. Pharmacotherapy 2000;20(6):644-52.
8. Hascoet JM, Hamon I, Boutroy MJ. Risks and benefits of therapies for apnoea in premature infants. Drug Saf 2000;23(5):363-79.
9. Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, et al. Caffeine therapy for apnea of prematurity. N Engl J Med 2006;354(20):2112-21.
10. Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, et al. Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med 2007;357(19):1893-902.
11. Darnall RA, Kattwinkel J, Nattie C, Robinson M. Margin of safety for discharge after apnea in preterm infants. Pediatrics 1997;100(5):795-801.
12. Martin RJ, Crowley MA. Respiratory Problems. In: Fanaroff AA, Fanaroff JM, editors. Klaus & Fanaroff?s Care of the High-risk Neonate. Sixth ed. Philadelphia: Elsevier Saunders 2013;263-4.
13. Kattwinkel J. Apnea in the Neonatal Period. Pediatrics in Review 1980;2(4):115-20.
14. Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 1978;187(1):1-7.
15. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: A study of infants with birth weights less than 1,500 gm. J Pediatr 1978;92(4):529-34.
16. Bakewell-Sachs S, Medoff-Cooper B, Escobar GJ, Silber JH, Lorch SA. Infant functional status: The timing of physiologic maturation of premature infants. Pediatrics 2009;123(5):e878-86.
17. Eichenwald EC, Aina A, Stark AR. Apnea frequently persists beyond term gestation in infants delivered at 24 to 28 weeks. Pediatrics 1997;100(3 Pt 1):354-9.
18. Rhein LM at al. Effects of caffeine on intermittent hypoxia in infants born prematurely: A randomized clinical trial. JAMA Pediatr 2014;168(3):250-7.